Macrogenics Inc (MGNX): Depreciation & Amortization
$7.17M
Year ended 2025-12-31
$5.89M
Trailing 12 months to 2026-06-30
-15.4%
3-year compound annual growth
-9.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.17M | -4.9% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $7.54M | -21.8% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $9.64M | -18.7% | 2026-03-09, From 2023-01-01 |
| 2022-12-31 | $11.87M | +5.4% | 2025-03-20, From 2022-01-01 |
| 2021-12-31 | $11.26M | -5.8% | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | $11.96M | -2.8% | 2023-03-15, From 2020-01-01 |
| 2019-12-31 | $12.31M | +34.3% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $9.16M | n/c | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $7.23M | -5.0% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $7.61M | +165.7% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $2.86M | +57.1% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $1.82M | n/c | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $1.20M | +20.0% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $1.00M | -9.1% | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | $1.10M | n/a | 2014-03-20, From 2011-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Macrogenics Inc (MGNX) | 2025-12-31 | $7.17M | -4.9% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $1.07M | -12.6% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $2.31M | -7.1% |
| Liquidia Corp (LQDA) | 2025-12-31 | $1.53M | -30.5% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.03M | +0.9% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $633.0K | -20.4% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $27.71M | -9.9% |
| Xencor Inc (XNCR) | 2025-12-31 | $10.51M | -13.2% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.77M | -12.1% |
Compare MGNX, ELTP, HRTX, LQDA side by side · Screen every company in Pharmaceutical Preparations ↗